- Reducing greenhouse gas emissions across the entire value chain
- Reducing the impact of medicinal products and activities on biodiversity
- Counterfeiting of medicinal products
Servier SAS
Greenhouse gas emissions & sustainability report data
In its 2022-2023 reporting, Servier SAS disclosed greenhouse gas emissions of 1.2M tCO2eq (2021/2022). By scope: Scope 1: 77.6K tCO2eq (2021/2022); Scope 2: 37.7K tCO2eq (2021/2022); Scope 3: 954.7K tCO2eq (2021/2022). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.2M tCO2eq (2021/2022)
2022-2023
Renewable Energy
13% (2022/2023)
of total energy
Water Usage
1.1M m3 (2022/2023)
2022-2023
Waste
80.8K tons (2022-2023)
2022-2023
Energy Use
422.0K MWh (2022/2023)
2022-2023
📊 Emissions by Scope (2022-2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 77.6K tCO2eq (2021/2022) |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 37.7K tCO2eq (2021/2022) |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 954.7K tCO2eq (2021/2022) |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022-2023 | 1.2M tCO2eq (2021/2022) |
| 2020-2021 | 33.7K tCO2e (2020/2021) |
| 2020 | 1.0M tons of CO2 (compared to 2015/2016) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced Scope 1 & 2 greenhouse gas emissions by 11% between 2021/2022 and 2022/2023
- Reduced Group’s energy consumption by 15% compared with the previous year
- Increased renewable electricity in the Group’s electricity consumption to more than 13%
- Reduced water consumption by 14%
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce Scope 1 & 2 greenhouse gas emissions by 16% and Scope 3 emissions by 10% compared with 2021/2022 by 2025
- Distribute an onsite biodiversity management guide for the Group’s entire real estate stock by 2025
- 100% of new brand-name medicines integrate ecodesign principles for the packaging by 2025
- Women in 40% of top management positions by 2025
📅 Medium-term
- Reduce Scope 1 & 2 greenhouse gas emissions by 42% and Scope 3 emissions by 25% compared with 2021/2022 by 2030
- 100% of French sites hold a BiodiverCity Life® or equivalent label by 2030
- 100% of the brand-name medicines integrate ecodesign principles by 2030
- Women in 40% of positions for Group governance bodies by 2030
🌱 ESG Focus Areas
PatientsEmployeesPartners and CommunitiesThe Planet